Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
SHAC Stock Summary
In the News
SHAC Financial details
Company Rating
Neutral
Market Cap
0
Income
17.76M
Revenue
0
Book val./share
7.75
Cash/share
8.07
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
31 Mar 2021
P/E
16.95
Forward P/E
-
PEG
-
P/S
-
P/B
1.3
P/C
-
P/FCF
-
Quick Ratio
441.1
Current Ratio
1.66
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.61
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-50.25%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
73.79%
Inst Trans
1.01%
ROA
7%
ROE
8%
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
23M
Shs Float
19.54M
-
-
-
-
Target Price
-
52W Range
9.68-10.0767
52W High
-
52W Low
-
RSI
-
Rel Volume
0.04
Avg Volume
61.93K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
-
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-
SHAC Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
Metric | History | 2020-12-31 | 2021-12-31 |
---|---|---|---|
2.02K | 2.02K | ||
Revenue per share | 0 | 0 | |
Net income per share | 0 | 0.7 | |
Operating cash flow per share | 0 | -0.06 | |
Free cash flow per share | 0 | -0.06 | |
Cash per share | 0 | 8.53 | |
Book value per share | 0 | 7.84 | |
Tangible book value per share | 0 | 7.84 | |
Share holders equity per share | 0 | 7.84 | |
Interest debt per share | 0.01 | 0 | |
Market cap | 278.59M | 265.76M | |
Enterprise value | 278.71M | 264.52M | |
P/E ratio | 0 | 13.96 | |
Price to sales ratio | 0 | 0 | |
POCF ratio | 0 | -161.27 | |
PFCF ratio | 0 | -161.27 | |
P/B Ratio | 12.09K | 1.25 | |
PTB ratio | 12.09K | 1.25 | |
EV to sales | 0 | 0 | |
Enterprise value over EBITDA | 0 | 29.83 | |
EV to operating cash flow | 0 | -160.51 | |
EV to free cash flow | 0 | -160.51 | |
Earnings yield | 0 | 0.07 | |
Free cash flow yield | 0 | -0.01 | |
Debt to equity | 6.41 | 0 | |
Debt to assets | 0.7 | 0 | |
Net debt to EBITDA | 0 | -0.14 | |
Current ratio | 0.13 | 4.49 | |
Interest coverage | 0 | -13.26 | |
Income quality | 0 | -0.19 | |
Dividend Yield | 0 | 0 | |
Payout ratio | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | |
Research and developement to revenue | 0 | 0 | |
Intangibles to total assets | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | |
Capex to revenue | 0 | 0 | |
Capex to depreciation | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | |
Graham number | 0 | 11.13 | |
ROIC | 0 | -0.01 | |
Return on tangible assets | 0 | 0.08 | |
Graham Net | -0.01 | 7.82 | |
Working capital | -162.29K | 1.48M | |
Tangible asset value | 23.05K | 212.75M | |
Net current asset value | -162.29K | -17.36M | |
Invested capital | 6.41 | 0 | |
Average receivables | 0 | 0 | |
Average payables | 0 | 0 | |
Average inventory | 0 | 0 | |
Days sales outstanding | 0 | 0 | |
Days payables outstanding | 0 | 0 | |
Days of inventory on hand | 0 | 0 | |
Receivables turnover | 0 | 0 | |
Payables turnover | 0 | 0 | |
Inventory turnover | 0 | 0 | |
ROE | 0 | 0.09 | |
Capex per share | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
Metric | History | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0.18 | 0.02 | 0.47 | 0.08 | 0.04 | |
Operating cash flow per share | 0 | 0 | -0.01 | -0.01 | -0.01 | |
Free cash flow per share | 0 | 0 | -0.01 | -0.01 | -0.01 | |
Cash per share | 8.05 | 8.05 | 8.04 | 8.04 | 8.07 | |
Book value per share | 7.4 | 7.4 | 7.63 | 7.71 | 7.75 | |
Tangible book value per share | 7.4 | 7.4 | 7.63 | 7.71 | 7.75 | |
Share holders equity per share | 7.4 | 7.4 | 7.63 | 7.71 | 7.75 | |
Interest debt per share | 0 | 0 | 0 | 0.01 | 0.04 | |
Market cap | 279.74M | 281.75M | 281.18M | 282.61M | 283.76M | |
Enterprise value | 278.4M | 280.5M | 280.29M | 281.93M | 283.14M | |
P/E ratio | 13.84 | 105.94 | 5.15 | 30.73 | 61.97 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | -2.68K | -3.24K | -771.41 | -1.41K | -1.13K | |
PFCF ratio | -2.68K | -3.24K | -771.41 | -1.41K | -1.13K | |
P/B Ratio | 1.31 | 1.32 | 1.28 | 1.27 | 1.27 | |
PTB ratio | 1.31 | 1.32 | 1.28 | 1.27 | 1.27 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 55.91 | 10.41K | 41.78 | 105.09 | 108.82 | |
EV to operating cash flow | -2.67K | -3.23K | -768.99 | -1.4K | -1.12K | |
EV to free cash flow | -2.67K | -3.23K | -768.99 | -1.4K | -1.12K | |
Earnings yield | 0.02 | 0 | 0.05 | 0.01 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | -0.27 | -46.25 | -0.13 | -0.25 | -0.24 | |
Current ratio | 10.72 | 4.49 | 5.47 | 4.06 | 1.66 | |
Interest coverage | -23.97 | -15.44 | -4.18 | -0.98 | -0.33 | |
Income quality | -0.02 | 24.57 | -0.05 | -0.09 | -0.22 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 5.41 | 1.96 | 9.03 | 3.72 | 2.64 | |
ROIC | 0 | -0.01 | 0 | 0 | 0 | |
Return on tangible assets | 0.02 | 0 | 0.06 | 0.01 | 0 | |
Graham Net | 7.37 | 7.38 | 7.61 | 7.7 | 7.74 | |
Working capital | 1.95M | 1.48M | 1.18M | 800.96K | 348.08K | |
Tangible asset value | 212.75M | 212.75M | 219.38M | 221.68M | 222.83M | |
Net current asset value | -17.5M | -17.36M | -10.8M | -8.82M | -8.69M | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.02 | 0 | 0.06 | 0.01 | 0.01 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
SHAC Frequently Asked Questions
What is SCP & CO Healthcare Acquisition Company stock symbol ?
SCP & CO Healthcare Acquisition Company is a US stock , located in Tampa of Fl and trading under the symbol SHAC
What is SCP & CO Healthcare Acquisition Company stock quote today ?
SCP & CO Healthcare Acquisition Company stock price is $- today.
Is SCP & CO Healthcare Acquisition Company stock public?
Yes, SCP & CO Healthcare Acquisition Company is a publicly traded company.